Saylor Hints at Flexibility: Myriad Prices 82% Odds Strategy Sells Bitcoin in 2026

The most telling part of this week wasn’t the number; it was the intent. After years of preaching “never sell,” Michael Saylor signaled that Strategy could part with some Bitcoin to “inoculate the market” and potentially fund a dividend. Prediction market traders immediately recalibrated: on Myriad—a Dastan product—the probability that the Virginia-based firm sells BTC this year has surged to 82%, up 69% week-over-week.

Here’s the real story: controlled selling as a signaling device. If Strategy executes a small, clearly framed sale, it doesn’t abandon the core long-Bitcoin thesis; it stresses test it. The move would establish three things at once: liquidity is real, governance is flexible, and the market doesn’t need a purity pledge to believe the strategy.

Key facts anchoring the shift: - Strategy holds more than 818,000 BTC—valued above $65 billion—and reported a $12.54 billion Q1 net loss, primarily from unrealized marks as BTC retraced. - Bitcoin is trading near $80,058 on Friday, roughly flat day-over-day, up 12% over 30 days, and about 36.5% below its October all-time high of $126,080. - Saylor told investors the firm would likely sell some BTC to demonstrate it can, while President and CEO Phong Le emphasized they’ll sell when it’s advantageous for shareholders. Saylor also told Fortune the company is effectively selling a Bitcoin derivative and retains the option to sell spot BTC to meet obligations. - On X, Saylor’s guidance now reads: buy more Bitcoin than you sell.

Why the “inoculation” matters: - Narrative management: Strategy’s equity often trades as a leveraged Bitcoin proxy. A one-off, rules-based sale reframes the stock from cult-holder to active treasury manager, which could broaden its investor base and reduce the “they can’t ever sell” overhang. Setting precedent can be more stabilizing than vows. - Basis mechanics: If the company occasionally converts BTC to cash (for a dividend or liability management), it may tighten the perceived basis between its equity and underlying BTC per share, trimming speculative discounts/premiums that can distort capital costs. - Execution credibility: Any sale can be programmatic and observable—likely via prime brokerage or OTC liquidity with transparent board authorization. On-chain movements would be tracked instantly; clean communication and size discipline would matter more than the act itself. - Psychological reset: Moving from absolutist “never sell” rhetoric to “buy more than you sell” introduces optionality without surrendering conviction. Many institutional allocators prefer durable policies over maximalist slogans; a modest dividend sourced from BTC could be read as strength, not capitulation. - Ethical consistency: Updating guidance to reflect real corporate flexibility reduces the risk of retail investors internalizing absolutist messages that a public company was never structurally able to guarantee. Clarity usually outperforms ideology over a full cycle.

What to watch next: - Formal policy signals: a board-sanctioned framework for opportunistic sales, dividend policy language, or liability-matching triggers would validate the “inoculation” narrative. - Microstructure tells: if a sale occurs, look for TWAP-like execution, minimal slippage against spot, and rapid disclosure—hallmarks of a treasury using professional liquidity. - Market reaction: Myriad’s 82% reading shows traders now price a non-trivial probability of action. If a small sale lands and the stock-BTC relationship tightens rather than cracks, that would confirm the signaling worked.

This isn’t a U-turn so much as a maturation. Strategy can still be net accumulative while occasionally converting a slice of its 818,000+ BTC for corporate objectives. If done deliberately, a sale could reduce narrative risk, lower cost of capital, and make the long-Bitcoin playbook more durable through the next drawdown.